Lumexa Imaging Holdings, Inc.

# Signal Note: RTW Investments Initiates $12M Position in Lumexa Imaging RTW's $12M entry into LMRI suggests conviction in the company's imaging technology platform, likely driven by upcoming clinical or regulatory catalysts in its core oncology/surgical visualization applications. The position size (~650k shares) indicates meaningful but measured conviction, consistent with RTW's data-driven thesis model. Key near-term catalysts to monitor: regulatory submissions, clinical trial readouts, or commercial traction milestones in intraoperative imaging.